Jack A. Khattar - 02 Apr 2025 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
President, CEO, Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
02 Apr 2025
Net transactions value
$0
Form type
4
Filing time
03 Apr 2025, 16:27:28 UTC
Previous filing
11 Mar 2025
Next filing
05 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Other +16,850 +1.7% 1,008,683 02 Apr 2025 Direct F1
transaction SUPN Common Stock Other -16,850 -1.6% 1,005,600 02 Apr 2025 By the KBT Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is filing this Form 4 to reflect the fact that 16,850 shares were transferred from the KBT Trust to the Reporting Person on April 2, 2025 without consideration and are now owned directly.